PF-00734200 20 mg QD
Sponsors
Pfizer
Conditions
Diabetes Mellitus, Type 2
Phase 2
12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin
CompletedNCT00473525
Start: 2007-07-31End: 2008-06-30Updated: 2010-06-24
Effect of PF-00734200 in Subjects With Type 2 Diabetes
CompletedNCT00618007
Start: 2008-02-29End: 2008-08-31Updated: 2011-06-27